TickerFacts.

PRF Technologies Ltd. (PRFX): Total Liabilities

Annual figures by period end, from SEC filings.

$2.71M
As of 2025-12-31
+27.5%
3-year compound annual growth
+18.1%
5-year compound annual growth
2020-12-31: $1.18M2021-12-31: $991.0K2022-12-31: $1.31M2023-12-31: $2.69M2024-12-31: $2.70M2025-12-31: $2.71M$2.71M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$2.71M+0.3%2026-03-26, Balance as of period end
2024-12-31$2.70M+0.4%2026-03-26, Balance as of period end
2023-12-31$2.69M+105.9%2025-04-07, Balance as of period end
2022-12-31$1.31M+31.9%2024-02-29, Balance as of period end
2021-12-31$991.0K-16.1%2023-03-15, Balance as of period end
2020-12-31$1.18Mn/a2022-03-16, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
PRF Technologies Ltd. (PRFX)2025-12-31$2.71M+0.3%
Bioadaptives, Inc. (BDPT)2025-12-31$2.36M+36.5%
Skinvisible, Inc. (SKVI)2025-12-31$10.39M+10.8%
Jupiter Neurosciences, Inc. (JUNS)2025-12-31$7.40M+264.3%
Talphera, Inc. (TLPH)2025-12-31$12.68M+23.9%
Impact Biomedical Inc. (IBO)2025-12-31$1.85M-85.8%
Lyell Immunopharma, Inc. (LYEL)2025-12-31$91.85M-15.0%
Genelux Corp (GNLX)2025-12-31$7.48M-11.4%
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$20.33M+127.9%

Compare PRFX, BDPT, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗